Oncology Decision Support Platform

Where patient voice meets clinical evidence

PharmASSIST gives oncology patients a structured way to share what matters to them — and gives clinicians a scannable summary before they walk in the room.

Explore Our Tools → Get In Touch

5.6×

increase in treatment preparedness with Shared Decision-Making

1 in 3

patients with cancer get a different decision role than they wanted

15 min

is all a community oncologist has per visit

For Patients

Give your patients a say in
their cancer treatment.

✓

5 minutes or less — completed on a tablet before the visit

✓

Plain language — no medical jargon, no prior knowledge required

✓

Covers what matters — diagnosis understanding, biomarker testing status, treatment preferences, and decision-making support

For Clinicians

Everything your care team needs before you walk in the room.

✓

Instant clinician summary — scannable in under a minute by any care team member

✓

Flags care gaps automatically — biomarker testing not done, treatment not understood, no decision support

✓

NCCN-aligned and mutation-specific — clinical notes and treatment options matched to the patient's results and preferences

Why It Matters

The evidence is clear. The gap is real.

Shared Decision-Making improves outcomes across every domain that matters in oncology — yet it rarely happens in practice.

↑

Satisfaction & Knowledge

Patients who experienced SDM consistently rated their care as excellent and reported significantly better understanding of their treatment options.

↓

Decisional Conflict & Regret

SDM produces measurable reductions in uncertainty and regret — outcomes that matter deeply when treatment decisions are high-stakes and often irreversible.

↑

Quality of Life & Adherence

Cancer patients with active involvement in decisions reported higher QoL, better treatment adherence, and less distress than those with passive roles.

5.6×

Greater treatment preparedness

SDM predicted a 5.6-fold increase in feeling prepared for treatment decisions compared to provider-led decisions.

1 in 3

Patients don't get a say

Patients with cancer report receiving a different decision-making role than they wanted — with measurably worse outcomes.

Our Tools

Decision support across oncology

Each module is built for a specific disease state and treatment decision point. New modules launch as clinical need is validated.

Lung Cancer

Live

Biomarker testing gaps and first-line treatment decisions for non-small cell lung cancer.

Launch Tool →

Breast Cancer

Coming Soon

Treatment decisions and preference profiling for HER2-positive, HR-positive, and triple-negative breast cancer.

Colorectal Cancer

Coming Soon

Biomarker testing and treatment preference support for metastatic colorectal cancer.

Get In Touch

Bring PharmASSIST to your patients

Whether you're a clinician, patient advocate, researcher, or institution — we'd like to hear from you.